26 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Women with in HIV-AIDS ... #HumanPapillomavirus ... #IDSA #Prevention ... #infections #HIVAIDS ... #pharmacology
Opportunistic Infections in HIV/AIDS: Syndromic Approach

WuidQ: Washington University ID Questions @WuidQ

#Opportunistic #Infections #OIs #HIVAIDS #Differential #Diagnosis
Opportunistic Infections ... in HIV/AIDS: Syndromic ... #Infections #OIs ... #HIVAIDS #Differential ... #Diagnosis #Systems
Syndromic Approach to Opportunistic Infections in HIV/AIDS: 

WuidQ: Washington University ID Questions @WuidQ

#Opportunistic #Infections #OIs #HIVAIDS
Infections in HIV ... /AIDS: WuidQ ... #Infections #OIs ... #HIVAIDS #Differential ... #Diagnosis #Systems
Blurry vision in a patient with HIV/AIDS
Anterior Segment:
 • Herpes zoster ophthalmicus
 • Keratitis (HSV, Staph,
/AIDS Anterior ... Acanthameoba, Candida ... Posterior Segment: • HIV ... #InfectiousDiseases ... #Diagnosis #Schema
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... in HIV-AIDS Preventing ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
Simplex Virus (HSV ... HIV-AIDS Treating ... #IDSA #Prevention ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... Encephalitis in HIV-AIDS ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... in HIV-AIDS Preventing ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... 21 days) Note: Systemic ... #Candidiasis #candida ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
and Treating HHV ... Disease (MCD) in HIV-AIDS ... and uncontrolled HIV ... #infections #HIVAIDS ... #pharmacology